Niagen Bioscience, Inc. - Common Stock (NAGE)

CUSIP: 171077407

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock
Shares outstanding
79,963,455
Total 13F shares
29,012,196
Share change
+4,071,254
Total reported value
$417,768,625
Put/Call ratio
132%
Price per share
$14.41
Number of holders
153
Value change
+$66,370,280
Number of buys
110
Number of sells
46

Quarterly Holders Quick Answers

What is CUSIP 171077407?
CUSIP 171077407 identifies NAGE - Niagen Bioscience, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of NAGE - Niagen Bioscience, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Chau Hoi Shuen Solina Holly
3/4/5
10%+ Owner
class O/S missing
19,294,356
$27,205,042 30 Sep 2022
BlackRock, Inc.
13F
Company
4.5%
3,617,071
$24,957,790 31 Mar 2025
13F
VANGUARD GROUP INC
13F
Company
4.4%
3,540,663
$24,430,575 31 Mar 2025
13F
Champion River Ventures Ltd
3/4/5
Director, 10%+ Owner
class O/S missing
11,408,715
$16,086,288 06 Sep 2023
Frank L. Jaksch Jr.
3/4/5
Director
mixed-class rows
2,339,231
mixed-class rows
$14,351,633 24 Jun 2025
Tieton Capital Management, LLC
13F
Company
2.5%
1,986,040
$13,704,000 31 Mar 2025
13F
D. E. Shaw & Co., Inc.
13F
Company
1.6%
1,283,790
$8,858,151 31 Mar 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.5%
1,179,217
$8,138,789 31 Mar 2025
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
1.2%
989,873
$6,830,124 31 Mar 2025
13F
STATE STREET CORP
13F
Company
1.2%
927,238
$6,397,942 31 Mar 2025
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.93%
744,490
$5,136,981 31 Mar 2025
13F
Qube Research & Technologies Ltd
13F
Company
0.89%
709,574
$4,896,061 31 Mar 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.75%
600,900
$4,146,210 31 Mar 2025
13F
ICONIQ Capital, LLC
13F
Company
0.73%
585,347
$4,038,894 31 Mar 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.65%
523,100
$3,609,390 31 Mar 2025
13F
NORTHERN TRUST CORP
13F
Company
0.5%
398,069
$2,746,676 31 Mar 2025
13F
TUDOR INVESTMENT CORP ET AL
13F
Company
0.46%
371,798
$2,565,406 31 Mar 2025
13F
Invesco Ltd.
13F
Company
0.46%
366,650
$2,529,885 31 Mar 2025
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.44%
352,136
$2,429,738 31 Mar 2025
13F
MARSHALL WACE, LLP
13F
Company
0.37%
298,977
$2,062,941 31 Mar 2025
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.37%
296,153
$2,043,456 31 Mar 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.37%
293,296
$2,023,742 31 Mar 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.33%
267,413
$1,845,150 31 Mar 2025
13F
MORGAN STANLEY
13F
Company
0.33%
264,945
$1,828,120 31 Mar 2025
13F
Hillsdale Investment Management Inc.
13F
Company
0.31%
244,772
$1,688,928 31 Mar 2025
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.28%
222,679
$1,536,485 31 Mar 2025
13F
Trexquant Investment LP
13F
Company
0.26%
209,786
$1,447,523 31 Mar 2025
13F
GABELLI FUNDS LLC
13F
Company
0.26%
204,800
$1,413,120 31 Mar 2025
13F
LAZARD ASSET MANAGEMENT LLC
13F
Company
0.26%
204,398
$1,410,000 31 Mar 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.23%
181,099
$1,249,583 31 Mar 2025
13F
Bank of New York Mellon Corp
13F
Company
0.22%
173,303
$1,195,793 31 Mar 2025
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.2%
159,970
$1,103,793 31 Mar 2025
13F
NAVELLIER & ASSOCIATES INC
13F
Company
0.16%
125,058
$1,056,740 31 Mar 2025
13F
RAYMOND JAMES FINANCIAL INC
13F
Company
0.19%
148,078
$1,021,738 31 Mar 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.18%
144,623
$997,899 31 Mar 2025
13F
Informed Momentum Co LLC
13F
Company
0.18%
143,048
$987,031 31 Mar 2025
13F
GAMCO INVESTORS, INC. ET AL
13F
Company
0.18%
142,800
$985,320 31 Mar 2025
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.17%
133,265
$918,000 31 Mar 2025
13F
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM
13F
Company
0.16%
125,200
$863,880 31 Mar 2025
13F
LOS ANGELES CAPITAL MANAGEMENT LLC
13F
Company
0.15%
122,820
$847,458 31 Mar 2025
13F
ROYAL BANK OF CANADA
13F
Company
0.14%
111,922
$773,000 31 Mar 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.13%
106,899
$737,603 31 Mar 2025
13F
Jump Financial, LLC
13F
Company
0.12%
96,430
$665,367 31 Mar 2025
13F
Silverberg Bernstein Capital Management LLC
13F
Company
0.12%
95,537
$659,205 31 Mar 2025
13F
PRUDENTIAL FINANCIAL INC
13F
Company
0.12%
95,385
$658,157 31 Mar 2025
13F
JANE STREET GROUP, LLC
13F
Company
0.11%
87,542
$604,040 31 Mar 2025
13F
BSW Wealth Partners
13F
Company
0.1%
81,847
$564,744 31 Mar 2025
13F
ALGERT GLOBAL LLC
13F
Company
0.09%
72,300
$499,000 31 Mar 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.09%
68,253
$470,946 31 Mar 2025
13F
RHUMBLINE ADVISERS
13F
Company
0.08%
67,420
$465,191 31 Mar 2025
13F

Institutional Holders of Niagen Bioscience, Inc. - Common Stock (NAGE) as of Q2 2025

As of 30 Jun 2025, Niagen Bioscience, Inc. - Common Stock (NAGE) was held by 153 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 29,012,196 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., D. E. Shaw & Co., Inc., Tieton Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, STATE STREET CORP, Nuveen, LLC, Connor, Clark & Lunn Investment Management Ltd., and Qube Research & Technologies Ltd. This page lists 153 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
138
Q2 2025 holders
153
Holder diff
15
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .